|
|
Ginseng,
American |
|
American Ginseng (English) Panax
quinquefolium (Botanical) Araliaceae (Plant Family) Ginseng
radix (Pharmacopeial)
|
|
| |
|
Overview |
|
American ginseng stimulates convalescence, rehabilitation, stamina and
strength through actions that are similar to those of its more famous Asian
cousin, Panax ginseng. In Asian countries, ginseng is regarded as the
king of herbs and is added to many everyday items, including beverages. The
Chinese associated ginseng with longevity, virility, strength, and wisdom as
early as 1 A.D., according to written accounts. As long as the roots are five or
six years old, at which time they contain suitable amounts of active plant
chemicals, American ginseng is considered similar enough to Asian ginseng
chemically to be used interchangeably.
Ginseng can be difficult to cultivate. It is susceptible to blights, needs
loamy, high-humus soil, and prefers 70% shade. This difficulty made it a good
export crop early on in American history, because it was plentiful here. In
1718, American ginseng brought five dollars a pound in Canton, China. In 1773,
55 tons of American ginseng were sold to the Chinese. By 1824, 380 tons were
exported. Even Daniel Boone traded ginseng.
Ginseng is classified as an adaptogen and antioxidant. Adaptogens increase
physiological resistance to stressors. Antioxidants function similarly, reducing
the negative consequences of free radicals. Modern research shows that ginseng
improves resistance to bacterial, viral, emotional, cognitive, muscular,
metabolic, and cardiovascular stressors, and suggests a plethora of ginseng or
ginseng constituent actions. While the elderly take it to diminish debility from
age-related illness, others take it to enhance physical and cognitive
performance. Ongoing studies are looking into ginseng for the treatment of
cancer, diabetes, cardiovascular disease, non–AIDS
related immune system depression, infertility, aging, and depression.
According to alternative medicine practitioners, American and Asian ginsengs
are indicated in stress, fatigue, convalescence and diabetes, and Siberian
ginseng in stress, fatigue, atherosclerosis, and impaired kidney function.
Confusion regarding which ginseng to use for stress, fatigue, and convalescence
(American, Asian, or Siberian) stems from the suggestion that active components
in one type are superior to those in another type, e.g., ginsenosides versus
eleutherosides. Such superiority has not been demonstrated. Early Russian
studies indicated that Siberian ginseng's positive effects exceed those of Asian
ginseng's. These results are supported by empirical reports, but are challenged
by investigators who question the validity of the studies and the quality of the
Siberian ginseng preparation. At this time, all three ginsengs are regarded as
adaptogens, all three share contraindication and side effect profiles, and
despite qualitative differences, each is used for similar indications. Cost,
standardization, and the reputation of the manufacturer may be the deciding
points in determining which product to use. |
|
|
Macro Description |
|
After two years' growth the leaves are five-lobed and palmate; after a few
more years, leaflets develop on prongs. Stem grows from a tap root and can reach
up to 16 inches in height. Small, greenish-white flowers grow in clusters and
produce red berries with two seeds.
Light beige, variably thick, gnarled root can appear similar in shape to the
human body, and has offshoots with long stringy hairs that can look like arms
and legs. The root is harvested at 4 to 6 years' age; age is determined by the
numbers of wrinkles on the neck of the root. The crude drug is prepared from the
lateral root and root hairs. |
|
|
Part Used/Pharmaceutical
Designations |
|
|
|
|
Constituents/Composition |
|
Dried root contains ginsenosides (Rb1 as marker); polysaccharide glycans
(quinquefolan A, B, and C) |
|
|
Commercial
Preparations |
|
White ginseng (dried, peeled) is prepared as liquid extracts, powders, or
capsules. |
|
|
Medicinal
Uses/Indications |
|
Traditional:
- Adaptogen
- Bitter tonic
- Restorative
- Alterative
Clinical applications:
- Diabetes
- Ulcer
- Edema
- Cancer
- Hypercholesterolemia
- Infertility
- Fatigue
- Frequent colds or viral illness
- Rehabilitation after acute illness
- To increase stamina and well
being
|
|
|
Pharmacology |
|
American ginseng reduces stress and fatigue and improves physical and mental
function. In studies in humans, American ginseng improves cholesterol ratios,
increases blood alcohol clearance, reduces liver toxicity, improves psychomotor
performance, helps control asthma, lowers blood sugar levels, and regulates
blood pressure and adrenocorticotropic hormone. Studies in humans also indicate
that American ginseng may be used as adjunctive therapy in the treatment of
diabetic neuropathy, reactive depression, psychologically-induced impotence, and
psychological disorders in children. Many of these studies involve other species
of ginseng, in particular, Panax ginseng (Asian ginseng). However, while
further study is needed for clarification, the two species do exert similar
actions.
Non-insulin-dependant diabetes is perhaps the condition most often used to
study the effects of constituents specific to American ginseng. The
polysaccharide glycans, quinquefolans A, B, and C are hypoglycemic in mice.
Ginsenoside Rb1 reduces concentrations of islet insulin to practically nothing.
|
|
|
Dosage Ranges and Duration of
Administration |
|
White ginseng standardized to 0.03% ginsenosides, designated as Rb1. The
recommended dose is: 1 to 2 g fresh root, 0.6 to 2 g dried root, or 200 to 600
mg liquid extract daily. Healthy persons using American ginseng for enhanced
physical or mental performance or to improve resistance to stressors should take
these doses in cycles of 15 to 20 days followed by two-week breaks.
For rehabilitation after an illness, the elderly should take 0.5 g bid for
three months; or, take 0.5 g bid for one month, followed by a two-month break,
and repeat cycle if desired. |
|
|
Side
Effects/Toxicology |
|
American ginseng is not considered to have side effects when used at the
recommended daily dose.
The American Herbal Products Association (AHPA) rates American ginseng as
class 2d: 2d indicates that specific restrictions apply; hypertension is the
specific restriction. |
|
|
Warnings/Contraindications/Precautions |
|
Similar contraindications to those for Asian ginseng may be applicable to
American ginseng: patients with acute illness, cardiovascular disease, diabetes,
or blood pressure disorders should use caution when taking ginseng. Pregnant
women should not take ginseng because its safety during pregnancy has not been
determined.
American ginseng is currently on the United Plant Savers (UpS) at-risk list,
meaning that the species is endangered due to overharvesting or lack of habitat.
Wisconsin currently produces the most ginseng, which is still sent primarily to
China. In 1905 the state passed a law that made it illegal to dig ginseng roots
until after they've been allowed to set seed (August 1). Poaching roots and
spreading fungus from cultivated to wild crops are as much of a threat to the
species as is overharvesting. |
|
|
Interactions |
|
Phenelzine
There have been reports of a possible interaction between ginseng and
phenelzine (Jones and Runikis 1987). This interaction has resulted in symptoms
ranging from manic-like episodes to headache and tremulousness. While the
mechanism for this suspected interaction remains unclear, it is thought that
ginsenosides inhibit cyclic AMP phosphodiesterase and affect cortical steroid
secretion. This activity may explain the psychoactive effects of ginsenosides
either alone or in combination with monoamine oxidase
inhibitors. Warfarin
There is a case report of an interaction between ginseng and warfarin in a
47-year-old heart valve replacement patient (Cheng 2000; Janetsky and Morreale
1997). Within two weeks of adding ginseng to his medication regimen, his INR
declined from 3.1 to 1.5. Upon discontinuing the ginseng, his INR value rose to
3.3 over a two week period. INR values should be monitored carefully in patients
taking ginseng with warfarin. Studies confirming this interaction have not been
performed and the mechanism remains unclear. |
|
|
Regulatory and Compendial
Status |
|
The U.S. FDA classifies ginseng as a dietary supplement. In Germany, ginseng
root is approved with nonprescription status, and in the United Kingdom it is
licensed on the General Sale List. |
|
|
References |
|
Bahrke M, Morgan P. Evaluation of the ergogenic properties of ginseng.
Sports Medicine. 1994;18:229-248.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic
Guide to Herbal Medicines. Boston, Mass: Integrative Medicine
Communications; 1998.
Blumenthal M, Riggins C. Popular Herbs in the U.S. Market: Therapeutic
Monographs. Austin, Tex: The American Botanical Council; 1997.
Chen X, et al. The effects of Panax quinquefolium saponin (PQS) and its
monomer ginsenoside on heart. Chung Kuo Chung Yao Tsa Chih.
1994;19:617-20, 640.
Cheng TO. Ginseng-warfarin interaction. ACC Curr J Rev. 2000;9(1):84.
Foster S. Herbal Renaissance: Growing, Using and Understanding Herbs in
the Modern World. Salt Lake City, Utah: Gibbs-Smith; 1993.
Huang KC. The Pharmacology of Chinese Herbs. Boca Raton, Fla: CRC
Press; 1993.
Janetsky K, Morreale A. Probable interaction between warfarin and ginseng.
Am J Health-Syst Pharm. 1997;54:692-693.
Jones BD, Runikis AM. Interaction of ginseng with phenelzine [letter]. J Clin
Psychopharmacol. 1987;7(3):201-202.
Kowalchik C, Hylton W, eds. Rodale's Illustrated Encyclopedia of
Herbs. Emmaus, Pa: Rodale Press; 1998.
Kwan CY. Vascular effects of selected antihypertensive drugs derived from
traditional medicinal herbs. Clin Exp Pharmacol Physiol. 1995;(suppl
1):S297-S299. Review.
Li J, et al. Panax quinquefolium saponins protect low density lipoproteins
from oxidation. Life Sci. 1999;64:53-62.
McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products
Association's Botanical Safety Handbook. Boca Raton, Fla: CRC Press;
1996.
Murphy LL, et al. Effect of American ginseng (Panax quinquefolium) on male
copulatory behavior in the rat. Physiol Behav. 1998;64:445-450.
Murray M. The Healing Power of Herbs: The Enlightened Person's Guide to
the Wonders of Medicinal Plants. Rocklin, Calif: Prima Publishing; 1995.
Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for
Health-care Professionals. London: The Pharmaceutical Press; 1996.
Oshima Y. Isolation and hypoglycemic activity of quinquefolans A, B, and C,
glycans of Panax quinquefolium roots. J Nat Prod.
1987;50:188-190.
Schulz V, Hänsel R, Tyler V. Rational Phytotherapy: A Physicians' Guide to
Herbal Medicine. 3rd ed. Berlin: Springer; 1998.
Thornton L. The ethics of wildcrafting. The Herb Quarterly.
1998:41-46.
Waki I. Effects of a hypoglycemic component of Ginseng radix on insulin
biosynthesis in normal and diabetic animals. J Pharmacobiodyn.
1982;5:547-554.
Yuan CS, et al. Modulation of American ginseng on brainstem GABAergic effects
in rats. J Ethnopharmacol. 1998;62:215-222.
|
|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |